Overutilization and underutilization of thrombolysis in routine clinical practice∗∗Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 2001
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular System & Hematology (Science Metrix)
- Drug Utilization (MeSH)
- Europe (MeSH)
- Fibrinolytic Agents (MeSH)
- Humans (MeSH)
- Myocardial Infarction (MeSH)
- Patient Selection (MeSH)
- Practice Patterns, Physicians' (MeSH)
- Streptokinase (MeSH)
- Stroke (MeSH)
- Survival Analysis (MeSH)
- Thrombolytic Therapy (MeSH)
- Tissue Plasminogen Activator (MeSH)
- United States (MeSH)